openPR Logo
Press release

Study on Global Renal Artery Embolization Market Highlights Key Development Factors, Competition Tracking, Production Rate, Cost Structure, Demand and Upcoming Trends during forecast 2018-2028

08-21-2018 12:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Fact.MR

Fact.MR

Embolization is a technique used to clog small blood vessels and block the blood flow, generally in cases of tumors. The renal arteries are responsible for proper functioning of the kidneys as they supply them blood. The renal arteries take a large volume of blood to be filtered by the kidneys. The renal artery embolization technique is used mainly to treat urological and neurological diseases. The renal artery embolization technique is a minimal invasive procedure that terminates the blood flow completely or partially. According to a Cancer Journal, the incidence of renal cell carcinoma is rising by 2–4% every year and in the U.S it is the 7th leading cancer type. According to a Cancer Journal, 200,000 people currently are estimated to have kidney cancer in the U.S. The renal artery embolization is required by patients dealing with autosomal dominant polycystic kidney disease, renal graft intolerance syndrome or any end stage renal disease. The renal artery embolization is being used to treat symptomatic renal arteriovenous malformations or renal artery aneurysms with less risk of complications as compared to other surgical alternatives.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1531

Renal Artery Embolization Market: Drivers and Challenges

Increasing incidence of renal cancer is the major factor expected to drive the growth of the renal artery embolization market over the forecast period. Other chronic renal diseases with increasing incidences such as renal angiomyolipomas, renal artery aneurysms and pseudoaneurysms, arteriovenous fistulas are also expected to contribute to the growth of the renal artery embolization market. Besides, the growing demand for minimally invasive procedures is also expected to drive the growth of the renal artery embolization market as it involves less healing time and is more efficient. However, low awareness regarding kidney-related diseases is expected to hinder the growth of the renal artery embolization market to some extent. Moreover, the procedures are very expensive and in majority of the preoperative settings, there is a lack of prospective randomized trials, which is why renal artery embolization is underutilized.

Renal Artery Embolization Market: Segmentation

Tentatively, the global renal artery embolization market can be segmented on the basis of disease indication, product type, end users and geography.

Based on disease indication, the global renal artery embolization market is segmented as:

• Renal Neoplasm
• Renal angiomyolipomas
• Renal Hemorrhage
• Renal malignancy
• Renal artery aneurysms and pseudoaneurysms
• Arteriovenous fistulas
• Others

Based on product type, the global renal artery embolization market is segmented as:

• Embolic Agents
o Sclerosants
o Metal Coils
o Particulate embolic agents
• Catheters

Based on end users, the global renal artery embolization market is segmented as:

• Hospitals
• Ambulatory Surgical Centers
• Catheterization Laboratories

Based on geography, the global renal artery embolization market is segmented as:

• North America
• Latin America
• Europe
• CIS & Russia
• Japan
• APEJ
• Middle East & Africa

Renal Artery Embolization Market: Overview

Kidney cancer is the most common type of renal neoplasm and its increasing prevalence is projected to be the major factor driving the growth of the renal artery embolization market. Increasing incidence of renal graft intolerance syndrome is also expected to drive the growth of the renal artery embolization market over the forecast period. Particulate embolic agents such as embosphere and polyvinyl alcoholparticle are the better embolic agents as compared to metal coils, absolute ethanol, glue or lipiodol. Small-sized catheters allow effective drainages and are mostly being preferred for renal artery embolization. These small-sized catheters prevent mucosal irritation, trauma, infections or any post-operative bleeding owing to which they are mostly preferred.

To know more about the Renal Artery Embolization Market Trends, Visit the link – https://www.factmr.com/report/1531/renal-artery-embolization-market

Renal Artery Embolization Market: Regional Outlook

The North America renal artery embolization market is expected to grow at a significant CAGR over the forecast period due to increasing incidence of renal neoplasm, renal graft intolerance syndrome and other chronic kidney diseases. Increasing awareness regarding renal artery disease among the general population and growing healthcare expenditure is also anticipated to the drive the growth of the renal artery embolization market in North America. The Europe renal artery embolization market is estimated to witness moderate growth over the forecast period due to moderate healthcare assessment and expenditure. Limited healthcare assessment facilities and poor GDP per capita are the factors responsible for the sluggish growth of the Asia-Pacific’s renal artery embolization market.

Renal Artery Embolization Market: Key Players

The key participants operating in the renal artery embolization market are Boston Scientific, Bard Medical, Biosense Webster, Cordis, Dextronix, Angiodynamics, Argon Medical Devices, Rocamed and Uromed.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1531

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Study on Global Renal Artery Embolization Market Highlights Key Development Factors, Competition Tracking, Production Rate, Cost Structure, Demand and Upcoming Trends during forecast 2018-2028 here

News-ID: 1191052 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period